mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.003 |
1 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |